AGRN and liver cancer: Since liver cancer cells actively stabilize FAs shortly after adherence to fibronectin [47], agrin ensures that components of the Hippo pathway are primarily excluded from the activated FAs by engaging ILK-PAK1 [54] (Figure 4).